Mohan V, Sandeep S, Deepa R, Shah B, Varghese C
Madras Diabetes Research Foundation & Dr Mohan's Diabetes Specialities Centre, Chennai, India.
Indian J Med Res. 2007 Mar;125(3):217-30.
India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the "diabetes capital of the world". According to the Diabetes Atlas 2006 published by the International Diabetes Federation, the number of people with diabetes in India currently around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are taken. The so called "Asian Indian Phenotype" refers to certain unique clinical and biochemical abnormalities in Indians which include increased insulin resistance, greater abdominal adiposity i.e., higher waist circumference despite lower body mass index, lower adiponectin and higher high sensitive C-reactive protein levels. This phenotype makes Asian Indians more prone to diabetes and premature coronary artery disease. At least a part of this is due to genetic factors. However, the primary driver of the epidemic of diabetes is the rapid epidemiological transition associated with changes in dietary patterns and decreased physical activity as evident from the higher prevalence of diabetes in the urban population. Even though the prevalence of microvascular complications of diabetes like retinopathy and nephropathy are comparatively lower in Indians, the prevalence of premature coronary artery disease is much higher in Indians compared to other ethnic groups. The most disturbing trend is the shift in age of onset of diabetes to a younger age in the recent years. This could have long lasting adverse effects on nation's health and economy. Early identification of at-risk individuals using simple screening tools like the Indian Diabetes Risk Score (IDRS) and appropriate lifestyle intervention would greatly help in preventing or postponing the onset of diabetes and thus reducing the burden on the community and the nation as a whole.
印度糖尿病患者数量位居世界之首,获得了“世界糖尿病之都”这一令人尴尬的称号。根据国际糖尿病联盟发布的《2006年糖尿病地图》,印度目前约有4090万糖尿病患者,除非立即采取预防措施,预计到2025年这一数字将增至6990万。所谓的“亚洲印度人表型”指的是印度人某些独特的临床和生化异常情况,包括胰岛素抵抗增加、腹部肥胖更明显,即尽管体重指数较低但腰围更大、脂联素水平较低以及高敏C反应蛋白水平较高。这种表型使亚洲印度人更容易患糖尿病和过早患冠状动脉疾病。其中至少部分原因是遗传因素。然而,糖尿病流行的主要驱动因素是与饮食模式变化和身体活动减少相关的快速流行病学转变,城市人口中糖尿病患病率较高就明显体现了这一点。尽管印度人糖尿病视网膜病变和肾病等微血管并发症的患病率相对较低,但与其他种族群体相比,印度人过早患冠状动脉疾病的患病率要高得多。最令人不安的趋势是近年来糖尿病发病年龄趋于年轻化。这可能会对国家的健康和经济产生长期的不利影响。使用印度糖尿病风险评分(IDRS)等简单筛查工具早期识别高危个体,并进行适当的生活方式干预,将极大地有助于预防或推迟糖尿病的发病,从而减轻社区乃至整个国家的负担。